Evidence map›Paper›PMID 30623207›Full record

ArticleCellular and molecular life sciences : CMLS2019

Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays.

Jan P Wintgens, Sven P Wichert, Luksa Popovic, Moritz J Rossner, Michael C Wehr

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. A programmable genetic platform for engineering noninvasive biosensors.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jan P WintgensDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Nussbaumstr. 7, 80336, Munich, Germany.ORCID http://orcid.org/0000-0002-1255-6837
Sven P WichertDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Luksa PopovicSystasy Bioscience GmbH, Adams-Lehmann-Str. 56, 80797, Munich, Germany.
Moritz J RossnerDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Nussbaumstr. 7, 80336, Munich, Germany.ORCID http://orcid.org/0000-0002-0667-3420
Michael C WehrDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Nussbaumstr. 7, 80336, Munich, Germany. Michael.Wehr@med.uni-muenchen.de.ORCID http://orcid.org/0000-0003-1770-8323
LMU Klinikum · DE

Funding

Deutsche Forschungsgemeinschaft WE 5683/1-1Horizon 2020 Framework Programme 675341
6 · The paper itself

Abstract

Receptor tyrosine kinases (RTKs) play key roles in various aspects of cell biology, including cell-to-cell communication, proliferation and differentiation, survival, and tissue homeostasis, and have been implicated in various diseases including cancer and neurodevelopmental disorders. Ligand-activated RTKs recruit adapter proteins through a phosphotyrosine (p-Tyr) motif that is present on the RTK and a p-Tyr-binding domain, like the Src homology 2 (SH2) domain found in adapter proteins. Notably, numerous combinations of RTK/adapter combinations exist, making it challenging to compare receptor activities in standardised assays. In cell-based assays, a regulated adapter recruitment can be investigated using genetically encoded protein-protein interaction detection methods, such as the split TEV biosensor assay. Here, we applied the split TEV technique to robustly monitor the dynamic recruitment of both naturally occurring full-length adapters and artificial adapters, which are formed of clustered SH2 domains. The applicability of this approach was tested for RTKs from various subfamilies including the epidermal growth factor (ERBB) family, the insulin receptor (INSR) family, and the hepatocyte growth factor receptor (HGFR) family. Best signal-to-noise ratios of ligand-activated RTK receptor activation was obtained when clustered SH2 domains derived from GRB2 were used as adapters. The sensitivity and robustness of the RTK recruitment assays were validated in dose-dependent inhibition assays using the ERBB family-selective antagonists lapatinib and WZ4002. The RTK split TEV recruitment assays also qualify for high-throughput screening approaches, suggesting that the artificial adapter may be used as universal adapter in cell-based profiling assays within pharmacological intervention studies.

Indexed as

src Homology DomainsA549 CellsAcrylamidesAnimalsBiological AssayCell Line, TumorErbB ReceptorsGRB2 Adaptor ProteinHumansLapatinibPC12 CellsProtein BindingPyrimidinesRatsReceptor Protein-Tyrosine KinasesReproducibility of ResultsAcrylamidesErbB ReceptorsGRB2 Adaptor ProteinLapatinibPyrimidinesReceptor Protein-Tyrosine KinasesWZ4002Cell-based assayLapatinibReceptor tyrosine kinasesSplit TEV recruitment assayTEV protease

Identifiers

PMID30623207
PMCPMC6675780
OpenAlexW2910544247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.